First off: Nash Pharmaceuticals Inc. We have multiple shots @ winning @ Phase II not to mention Phase III. Check the plethora of news releases regarding Lead Compound NP-160, Lead Compound NP-178, & Lead Compound NP-135, and potential Big Pharma partnership(s).
Next Up: Cannabix Technologies Inc. IMO, there will be no batmobiles, vans, trains, planes, cargo ships, etc etc as it relates to the Breath Collection Unit (BCU) and FAIMS analyzer (Black|Box). Picture if you will...the analyzer will remain in the scout car. The officer pulls over the suspect. Suspect BLO's into the BCU. The officer takes the BCU along with standard request for DL, Reg, POI. While the officer runs the information through the system in his/her scout car, he also runs the breath sample through the analyzer *which is a lot smaller than Draegers spit analyzer). Thereafter, the officer will respond accordingly. Therefore, the BCU and the FAIMS "instrument" will be sold as one complete unit - not to be sold seperately. The only question is price point. To which I will add, Cannabix currently has only one known competitor. It's my belief Cannabix's current "instrumentation" exceeds that of the known competition. Maybe by far >>>
Lastly: Breathtec Biomedical Inc. IMO, Breathtec simply does not have as many hoops to jump through with the technology. What I question is whether or not management will sit on the tech @ Breathtec versus putting it out there to start generating revenues ASAP. IMO, Breathtec's need for cash exeeds Cannabix by far. The pending trials are cash hungry cows. Short of a Big Pharma partnership deal that comes with mad cow cash, were looking at either PP's or Reverse Splits to keep things moving along. Common shareholders have already been kicked in the teeth, cut to the core, and the mission epically abandoned by management once. We need a win here fast and can't simply wait until Cannabix completes all of what it must do (IMO, more complex issues) to get to commercialization.
GL2ALL
/////AMG
Red Pills
